Literature DB >> 30792568

Immunomodulatory Bonds of the Partnership between Dendritic Cells and T Cells.

Jessica Bourque1, Daniel Hawiger1.   

Abstract

By acquiring, processing, and presenting both foreign and self-antigens, dendritic cells (DCs) initiate T cell activation that is shaped through the immunomodulatory functions of a variety of cell-membrane-bound molecules including BTLA-HVEM, CD40-CD40L, CTLA-4-CD80/CD86, CD70-CD27, ICOS-ICOS-L, OX40-OX40L, and PD-L1-PD-1, as well as several key cytokines and enzymes such as interleukin-6 (IL-6), IL-12, IL-23, IL-27, transforming growth factor-beta 1 (TGF-β1), retinaldehyde dehydrogenase (Raldh), and indoleamine 2,3-dioxygenase (IDO). Some of these distinct immunomodulatory signals are mediated by specific subsets of DCs, therefore contributing to the functional specialization of DCs in the priming and regulation of immune responses. In addition to responding to the DC-mediated signals, T cells can reciprocally modulate the immunomodulatory capacities of DCs, further refining immune responses. Here, we review recent studies, particularly in experimental mouse systems, that have delineated the integrated mechanisms of crucial immunomodulatory pathways that enable specific populations of DCs and T cells to work intimately together as single functional units that are indispensable for the maintenance of immune homeostasis.

Entities:  

Keywords:  T cell; T cell differentiation; dendritic cell; effector T cell; immunoregulation; regulatory T cell

Mesh:

Year:  2018        PMID: 30792568      PMCID: PMC6380512          DOI: 10.1615/CritRevImmunol.2018026790

Source DB:  PubMed          Journal:  Crit Rev Immunol        ISSN: 1040-8401            Impact factor:   2.214


  239 in total

1.  CD40 triggering of heterodimeric IL-12 p70 production by dendritic cells in vivo requires a microbial priming signal.

Authors:  O Schulz; A D Edwards; M Schito; J Aliberti; S Manickasingham; A Sher; C Reis e Sousa
Journal:  Immunity       Date:  2000-10       Impact factor: 31.745

2.  The CD28-related molecule ICOS is required for effective T cell-dependent immune responses.

Authors:  A J Coyle; S Lehar; C Lloyd; J Tian; T Delaney; S Manning; T Nguyen; T Burwell; H Schneider; J A Gonzalo; M Gosselin; L R Owen; C E Rudd; J C Gutierrez-Ramos
Journal:  Immunity       Date:  2000-07       Impact factor: 31.745

3.  Requirement for CD70 in CD4+ Th cell-dependent and innate receptor-mediated CD8+ T cell priming.

Authors:  Vadim Y Taraban; Tania F Rowley; David F Tough; Aymen Al-Shamkhani
Journal:  J Immunol       Date:  2006-09-01       Impact factor: 5.422

4.  CD160 inhibits activation of human CD4+ T cells through interaction with herpesvirus entry mediator.

Authors:  Guifang Cai; Anukanth Anumanthan; Julia A Brown; Edward A Greenfield; Baogong Zhu; Gordon J Freeman
Journal:  Nat Immunol       Date:  2008-01-13       Impact factor: 25.606

5.  B7h, a novel costimulatory homolog of B7.1 and B7.2, is induced by TNFalpha.

Authors:  M M Swallow; J J Wallin; W C Sha
Journal:  Immunity       Date:  1999-10       Impact factor: 31.745

6.  CD4+ T Cell Help Confers a Cytotoxic T Cell Effector Program Including Coinhibitory Receptor Downregulation and Increased Tissue Invasiveness.

Authors:  Tomasz Ahrends; Aldo Spanjaard; Bas Pilzecker; Nikolina Bąbała; Astrid Bovens; Yanling Xiao; Heinz Jacobs; Jannie Borst
Journal:  Immunity       Date:  2017-11-07       Impact factor: 31.745

7.  1,25-Dihydroxyvitamin D3 selectively modulates tolerogenic properties in myeloid but not plasmacytoid dendritic cells.

Authors:  Giuseppe Penna; Susana Amuchastegui; Nadia Giarratana; Kenn C Daniel; Marisa Vulcano; Silvano Sozzani; Luciano Adorini
Journal:  J Immunol       Date:  2007-01-01       Impact factor: 5.422

8.  Cutting edge: IL-27 induces the transcription factor c-Maf, cytokine IL-21, and the costimulatory receptor ICOS that coordinately act together to promote differentiation of IL-10-producing Tr1 cells.

Authors:  Caroline Pot; Hulin Jin; Amit Awasthi; Sue Min Liu; Chen-Yen Lai; Rajat Madan; Arlene H Sharpe; Christopher L Karp; Shi-Chuen Miaw; I-Cheng Ho; Vijay K Kuchroo
Journal:  J Immunol       Date:  2009-07-01       Impact factor: 5.422

9.  B7h-expressing dendritic cells and plasma B cells mediate distinct outcomes of ICOS costimulation in T cell-dependent antibody responses.

Authors:  Kevin Larimore; Linda Liang; Sonia Bakkour; William C Sha
Journal:  BMC Immunol       Date:  2012-06-11       Impact factor: 3.615

10.  CD8 T cell memory to a viral pathogen requires trans cosignaling between HVEM and BTLA.

Authors:  Rachel Flynn; Tarun Hutchinson; Kenneth M Murphy; Carl F Ware; Michael Croft; Shahram Salek-Ardakani
Journal:  PLoS One       Date:  2013-10-29       Impact factor: 3.240

View more
  26 in total

Review 1.  Natural and Induced Tolerogenic Dendritic Cells.

Authors:  Courtney A Iberg; Daniel Hawiger
Journal:  J Immunol       Date:  2020-02-15       Impact factor: 5.422

2.  Tissue sodium content in patients with systemic lupus erythematosus: association with disease activity and markers of inflammation.

Authors:  D A Carranza-León; A Oeser; A Marton; P Wang; J C Gore; J Titze; C M Stein; C P Chung; M J Ormseth
Journal:  Lupus       Date:  2020-02-18       Impact factor: 2.911

Review 3.  Regulatory T cells in ischemic stroke.

Authors:  Hong-Yun Wang; Jun-Rui Ye; Li-Yuan Cui; Shi-Feng Chu; Nai-Hong Chen
Journal:  Acta Pharmacol Sin       Date:  2021-03-26       Impact factor: 6.150

4.  Fcγ receptors and toll-like receptor 9 synergize to drive immune complex-induced dendritic cell maturation.

Authors:  Nicole L J Nelson; Cheryl M Zajd; Michelle R Lennartz; Edmund J Gosselin
Journal:  Cell Immunol       Date:  2019-08-03       Impact factor: 4.868

5.  Non-severe burn injury increases cancer incidence in mice and has long-term impacts on the activation and function of T cells.

Authors:  Lucy W Barrett; Vanessa S Fear; Bree Foley; Katherine Audsley; Samantha Barnes; Hannah Newnes; Alison McDonnell; Fiona M Wood; Mark W Fear; Jason Waithman
Journal:  Burns Trauma       Date:  2022-04-29

Review 6.  Variegated Outcomes of T Cell Activation by Dendritic Cells in the Steady State.

Authors:  Jessica Bourque; Daniel Hawiger
Journal:  J Immunol       Date:  2022-02-01       Impact factor: 5.426

7.  Peptides from allergenic lipocalins bind to formyl peptide receptor 3 in human dendritic cells to mediate TH2 immunity.

Authors:  Dominik Klaver; Beate Posch; Anita Geisler; Martin Hermann; Norbert Reider; Christine Heufler
Journal:  J Allergy Clin Immunol       Date:  2019-07-19       Impact factor: 10.793

Review 8.  Re-Programming Autoreactive T Cells Into T-Regulatory Type 1 Cells for the Treatment of Autoimmunity.

Authors:  Patricia Solé; Pere Santamaria
Journal:  Front Immunol       Date:  2021-07-15       Impact factor: 7.561

Review 9.  Targeting Dendritic Cells with Antigen-Delivering Antibodies for Amelioration of Autoimmunity in Animal Models of Multiple Sclerosis and Other Autoimmune Diseases.

Authors:  Courtney A Iberg; Daniel Hawiger
Journal:  Antibodies (Basel)       Date:  2020-06-15

10.  Interaction between HLA-G and NK cell receptor KIR2DL4 orchestrates HER2-positive breast cancer resistance to trastuzumab.

Authors:  Guoxu Zheng; Zhangyan Guo; Weimiao Li; Wenjin Xi; Baile Zuo; Rui Zhang; Weihong Wen; An-Gang Yang; Lintao Jia
Journal:  Signal Transduct Target Ther       Date:  2021-06-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.